Compounds for suppressing a peripheral nerve disorder induced by an anti - cancer agent

Details for Australian Patent Application No. 2011211294 (hide)

Owner Takeda Pharmaceutical Company Limited

Inventors Kitamoto, Naomi

Agent Griffith Hack

Pub. Number AU-A-2011211294

PCT Pub. Number WO2011/093512

Priority 2010-015935 27.01.10 JP

Filing date 26 January 2011

Wipo publication date 4 August 2011

International Classifications

A61K 31/216

A61K 31/282

A61K 31/337 - having four-membered rings, e.g. taxol

A61K 31/41 - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/4192 - 1,2,3-Triazoles

A61K 31/4196 - 1,2,4-Triazoles

A61K 31/428 - condensed with carbocyclic rings

A61K 31/4545

A61K 31/69 - Boron compounds

A61P 25/02 Drugs for disorders of the nervous system

Event Publications

20 September 2012 PCT application entered the National Phase

  PCT publication WO2011/093512 Priority application(s): WO2011/093512

4 October 2012 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 24 Aug 2012

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011211303-Refrigerant composition comprising difluoromethane (HFC32) and 2,3,3,3-tetrafluoropropene (HFO1234yf)

2011211291-Polynucleotide encoding acyl-CoA synthetase homolog and method for using the same